Test-retest reproducibility of FDG-PET/CT uptake in cancer patients within a qualified and calibrated local network (scientific article published on 25 October 2018)

Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.

Q33921056

Variability in PET quantitation within a multicenter consortium

Q34000970

Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

Q34336023

A concordance correlation coefficient to evaluate reproducibility

Q34527574

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

Q34978457

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Q35043725

Design considerations for using PET as a response measure in single site and multicenter clinical trials.

Q35653277

Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials

Q36104734

Use of PET for monitoring cancer therapy and for predicting outcome

Q36152615

Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials

Q36363737

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Q36425061

Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.

Q36567875

Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings

Q36626050

Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience

Q37348938

EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies

Q37433290

Evaluation of Cross-Calibrated 68Ge/68Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter Trials

Q37558197

Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.

Q37721524

Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.

Q38072413

Repeatability of SUV in Oncologic 18F-FDG PET.

Q38945159

Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.

Q39216200

Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis

Q40635561

Development of a traceable calibration methodology for solid (68)Ge/(68)Ga sources used as a calibration surrogate for (18)F in radionuclide activity calibrators

Q43144716

Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies

Q43275688

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

Q46312531

Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: influence of attenuation correction method and examination interval

Q46647418

Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.

Q46720131

Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis

Q47913737

Computer programs for the concordance correlation coefficient.

Q51625682

Reproducibility of metabolic measurements in malignant tumors using FDG PET

Q73192444

P433

issue

P407